SCHEMBL20110024

SCHEMBL20110024

CC(C)(C)c1ccc2oc3ccc(O)cc3c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.48
TYR P14679 1/20 0.48
ALDH1A1 P00352 5/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
HPGD P15428 3/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
HTT P42858 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2D6 P10635 1/20 0.48
GPR55 Q9Y2T6 1/20 0.48
PON1 P27169 1/20 0.46
MAOA P21397 2/20 0.46
MAPT P10636 5/20 0.45
ALOX15 P16050 3/20 0.45
HSD17B10 Q99714 3/20 0.45
KDM4E B2RXH2 2/20 0.45
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23056731 0.88 PON1 (0.54) LMNATYRALDH1A1SMN1; SMN2HPGD
SCHEMBL16806203 0.84 PON1 (0.51) LMNATYRALDH1A1SMN1; SMN2HPGD
SCHEMBL5308204 0.82 MAPT (0.64) LMNAALDH1A1SMN1; SMN2HPGDMEN1
SCHEMBL10910687 0.81 ALDH1A1 (0.67) LMNATYRALDH1A1SMN1; SMN2HPGD
SCHEMBL24272474 0.81 PON1 (0.49) LMNAALDH1A1SMN1; SMN2HPGDMEN1
SCHEMBL25452995 0.81 PON1 (0.49) LMNATYRALDH1A1SMN1; SMN2HPGD
SCHEMBL12060916 0.79 MAPT (0.53) LMNAALDH1A1SMN1; SMN2HPGDMEN1
SCHEMBL25688320 0.79 MAPT (0.49) ALDH1A1SMN1; SMN2HPGDHTTPON1
SCHEMBL19152198 0.78 PON1 (0.46) ALDH1A1MEN1KMT2APON1MAPT
SCHEMBL12181810 0.77 PON1 (0.57) ALDH1A1SMN1; SMN2HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10693084-B2 Compound for organic light-emitting device and organic light-emitting device including same SFC CO., LTD. (KR) 2020-06-23 US disclosed
US-20180123055-A1 COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME SFC CO., LTD. (KR) 2018-05-03 US disclosed
US-20180123055-A1 COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME SFC CO., LTD. (KR) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10693084-B2 Compound for organic light-emitting device and organic light-emitting device including same CYP1B1, CYP1A1, CRY2 LMNA 1343/4885TYR 480/4885ALDH1A1 5/4885
US-20180123055-A1 COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME CYP1B1, CYP1A1, CRY2 LMNA 1343/4885TYR 480/4885ALDH1A1 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.